Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making.
about
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementThe Risk of Some Veterinary Antimicrobial Agents on Public Health Associated with Antimicrobial Resistance and their Molecular BasisVancomycin treatment of infective endocarditis is linked with recently acquired obesity.Prophylactic antibiotic administration for post cardiothoracic surgery sternal wounds: a retrospective studyFriend turned foe: evolution of enterococcal virulence and antibiotic resistanceUse of antimicrobial agents in veterinary medicine and implications for human health.Effect of long-term antibiotic use on weight in adolescents with acne.Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains.Can probiotics improve the environmental microbiome and resistome of commercial poultry production?Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?New transposon Tn6133 in methicillin-resistant Staphylococcus aureus ST398 contains vga(E), a novel streptogramin A, pleuromutilin, and lincosamide resistance gene.Collaborative study of a microbiological screening method (three-plate) for the banned antimicrobial growth promotors tylosin, virginiamycin, spiramycin, zinc bacitracin and avoparcin in animal feed.Enterococcus in surface waters from the Des Moines River (Iowa) watershed: location, persistence and vancomycin resistance.Comparison of the loads and antibiotic-resistance profiles of Enterococcus species from conventional and organic chicken carcasses in South Korea.Effects of poly-β-hydroxybutyrate (PHB) on Siberian sturgeon (Acipenser baerii) fingerlings performance and its gastrointestinal tract microbial community.
P2860
Q26798630-CF3BDFAB-595A-43AB-B844-0F84E408063DQ28078439-D9543420-12FF-4266-BA96-EA14334967C0Q33531791-BB4F6262-FDB7-4308-BF3B-05E10684A9C9Q35238093-6449B859-D471-4E15-8747-FF605D966575Q35257970-D1D8AE7A-57CB-4D5B-A9FA-099A45D58ECCQ36260950-B114E4ED-4356-49B4-8EC2-12B01749D69FQ36684193-73E77F74-7B2A-4A07-8892-E7B09BD01034Q37105688-30AA8E8A-F5F6-481A-883C-29BCD80F449FQ37295861-031A2F8F-E75D-4635-8193-23DC7C70B1C7Q38064807-36A7A978-7970-4B30-9E5D-4DD84F4FF279Q38627294-28B14205-9782-4207-A483-EB2B657C2CCEQ43292117-FC8300E1-73FF-4DB5-8FDF-75450436A4A0Q44103174-B42D7D3F-8937-4447-9555-E0A855A5ACFDQ46273285-05A45D7E-681C-4F9E-A961-EEDED1B39927Q49042918-2606833F-F63A-428E-8158-196D98DAEC06
P2860
Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Avoparcin and virginiamycin as ...... or science in decision-making.
@ast
Avoparcin and virginiamycin as ...... or science in decision-making.
@en
type
label
Avoparcin and virginiamycin as ...... or science in decision-making.
@ast
Avoparcin and virginiamycin as ...... or science in decision-making.
@en
prefLabel
Avoparcin and virginiamycin as ...... or science in decision-making.
@ast
Avoparcin and virginiamycin as ...... or science in decision-making.
@en
P2093
P1476
Avoparcin and virginiamycin as ...... or science in decision-making.
@en
P2093
P304
P356
10.1046/J.1469-0691.2000.00128.X
P577
2000-09-01T00:00:00Z